Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
investing
4
×
life sciences
national blog main
boston top stories
clinical trials
fda
san francisco blog main
san francisco top stories
startups
cancer
deals
national top stories
new york blog main
new york top stories
san francisco
sanofi
software
agios pharmaceuticals
alphabet
ame cloud ventures
american diabetes association
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
boulder/denver blog main
boulder/denver top stories
brexanolone
broad institute of harvard and mit
brook byers
camp4 therapeutics
cancer drugs
cancer immunotherapy
charles chu
clostridium difficile
colleen cutcliffe
computational biology
crispr
What
today
4
×
available
ahead
ambien
american
annual
asco
attendees
attention
balance
based
big
bio
biome
biosciences
biotech
blood
camp’s
cancer
cas
cash
cheaper
chicago
city
clinical
combinations
community’s
company’s
course
crispr
days
develop
development
diabetes
diagnostics
discover
drug
expanding
expects
experimental
Language
unset
Current search:
biotech
×
investing
×
today
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More